Literature DB >> 18040143

MALT lymphoma : recent advances in aetiology and molecular genetics.

Ming-Qing Du1.   

Abstract

Mucosa-associated lymphoid tissue (MALT) lymphoma is a common low grade B-cell lymphoma arising from a background of chronic inflammatory disease at a number of mucosal sites. Those originating in the stomach are causatively linked to Helicobacter pylori infection and eradication of the bacterium with antibiotics leads to long-term complete regression of the lymphoma in aproximately 70% of cases. Now, there is further evidence of linking Campylobacter jejuni, Borrelia burgdorferi and Chlamydia psittaci infection with immunoproliferative small intestine disease, MALT lymphoma of the skin and ocular adnexa respectively. t(11;18)/API2-MALT1, t(1;14)/IGH-BCL10, t(14;18)/IGH-MALT1 and t(3;14)/IGH-FOXP1 occur at considerably variable incidences in MALT lymphomas of different sites. The first three chromosome translocations are specifically associated with the MALT lymphoma entity and the oncogenic products of these translocations have been shown to target a common molecular pathway, i.e. the nuclear factor-kappaB pathway. Here, I review the recent advances in our understanding of the association of microbial pathogens with MALT lymphoma of various sites and the molecular genetics underlying the lymphoma development.

Entities:  

Mesh:

Year:  2007        PMID: 18040143     DOI: 10.3960/jslrt.47.31

Source DB:  PubMed          Journal:  J Clin Exp Hematop        ISSN: 1346-4280


  26 in total

Review 1.  NF-κB signaling pathways regulated by CARMA family of scaffold proteins.

Authors:  Marzenna Blonska; Xin Lin
Journal:  Cell Res       Date:  2010-12-28       Impact factor: 25.617

2.  Molecular allelokaryotyping of T-cell prolymphocytic leukemia cells with high density single nucleotide polymorphism arrays identifies novel common genomic lesions and acquired uniparental disomy.

Authors:  Daniel Nowak; Emilie Le Toriellec; Marc-Henri Stern; Norihiko Kawamata; Tadayuki Akagi; Martin J Dyer; Wolf-Karsten Hofmann; Seishi Ogawa; H Phillip Koeffler
Journal:  Haematologica       Date:  2009-03-10       Impact factor: 9.941

3.  Descriptive epidemiology of ophthalmic and ocular adnexal non-Hodgkin's lymphoma.

Authors:  Roxana Moslehi; F Bruce Coles; Maria J Schymura
Journal:  Expert Rev Ophthalmol       Date:  2011

4.  Mixed large cell neuroendocrine carcinoma and mucosa-associated lymphoid tissue lymphoma of the lung: A case report.

Authors:  Takeshi Matsumoto; Yukihiro Imai; Yasuhiro Kosaka; Takashi Shintani; Keisuke Tomii
Journal:  Oncol Lett       Date:  2015-02-27       Impact factor: 2.967

Review 5.  Ocular adnexal marginal zone lymphoma of mucosa-associated lymphoid tissue.

Authors:  Dimitrios Kalogeropoulos; Alexandra Papoudou-Bai; Panagiotis Kanavaros; Chris Kalogeropoulos
Journal:  Clin Exp Med       Date:  2017-09-22       Impact factor: 3.984

Review 6.  The Paracaspase MALT1.

Authors:  Janna Hachmann; Guy S Salvesen
Journal:  Biochimie       Date:  2015-09-16       Impact factor: 4.079

Review 7.  Malt1 and cIAP2-Malt1 as effectors of NF-kappaB activation: kissing cousins or distant relatives?

Authors:  Lara M Kingeter; Brian C Schaefer
Journal:  Cell Signal       Date:  2009-09-19       Impact factor: 4.315

Review 8.  Cytotoxic T cells in H. pylori-related gastric autoimmunity and gastric lymphoma.

Authors:  Mathijs P Bergman; Mario M D'Elios
Journal:  J Biomed Biotechnol       Date:  2010-06-22

Review 9.  Helicobacter and gastric malignancies.

Authors:  António Carlos Ferreira; Hajime Isomoto; Masatsugu Moriyama; Toshio Fujioka; José Carlos Machado; Yoshio Yamaoka
Journal:  Helicobacter       Date:  2008-10       Impact factor: 5.753

10.  Emu-BCL10 mice exhibit constitutive activation of both canonical and noncanonical NF-kappaB pathways generating marginal zone (MZ) B-cell expansion as a precursor to splenic MZ lymphoma.

Authors:  Zhaoyang Li; Hongsheng Wang; Liquan Xue; Dong-Mi Shin; Derry Roopenian; Wu Xu; Chen-Feng Qi; Mark Y Sangster; Carlos J Orihuela; Elaine Tuomanen; Jerold E Rehg; Xiaoli Cui; Quangeng Zhang; Herbert C Morse; Stephan W Morris
Journal:  Blood       Date:  2009-08-20       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.